UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000040346
Receipt No. R000046041
Scientific Title FACTOR Xa INHIBITORS FOR VENOUS THROMBOEMBOLISM MANAGEMENT IN PATIENT WITH CANCER
Date of disclosure of the study information 2020/06/12
Last modified on 2020/05/09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title FACTOR Xa INHIBITORS FOR VENOUS THROMBOEMBOLISM MANAGEMENT IN PATIENT WITH CANCER: A META-ANALYSIS
Acronym FACTOR Xa INHIBITORS FOR VENOUS THROMBOEMBOLISM MANAGEMENT IN PATIENT WITH CANCER
Scientific Title FACTOR Xa INHIBITORS FOR VENOUS THROMBOEMBOLISM MANAGEMENT IN PATIENT WITH CANCER
Scientific Title:Acronym FACTOR Xa INHIBITORS FOR VTE MANAGEMENT IN CANCER: A META-ANALYSIS
Region
Asia(except Japan)

Condition
Condition In Cancer patients with VTE or risk of VTE
Classification by specialty
Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Since more randomized clinical trials (RCTs) are becoming available, we chose to perform a meta-analysis of randomized trials to assess the effectiveness of factor Xa inhibitor for venous thromboembolism management in patients with cancer
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Others
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes the recurrent VTE or VTE events rates and major bleeding incidence
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria any randomised controlled trials in which patients with a history of cancer or active cancer were allocated to receive an oral factor Xa inhibitor in one arm of treatment for the either treatment or prophylaxis of VTE
Key exclusion criteria All phase II trials, trials involving anti-platelet in control arm of treatment, trials using anticoagulant as post-procedure prophylaxis of VTE
Target sample size 5

Research contact person
Name of lead principal investigator
1st name Johanes
Middle name
Last name Nugroho
Organization Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya
Division name Department of Cardiology and Vascular Medicine
Zip code 60131
Address Jl. Mayjen Prof. Dr. Moestopo 47
TEL +6282139090953
Email j.nugroho.eko@fk.unair.ac.id

Public contact
Name of contact person
1st name Johanes
Middle name
Last name Nugroho
Organization Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga, Dr. Soeto
Division name Department of Cardiology and Vascular Medicine
Zip code 60131
Address Jl. Mayjen Prof. Dr. Moestopo 47
TEL +6282139090953
Homepage URL
Email j.nugroho.eko@fk.unair.ac.id

Sponsor
Institute Dr. Soetomo General Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Komite Etik Penelitian Kesehatan RSUD Dr Soetomo Surabaya
Address Jalan Mayjen. Prof. Dr. Moestopo No. 6-8, Surabaya, Jawa Timur 60286
Tel +62315501011
Email kontak@rsudrsoetomo.jatimprov.go.id

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 2000
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 04 Month 01 Day
Date of IRB
2020 Year 04 Month 23 Day
Anticipated trial start date
2020 Year 04 Month 24 Day
Last follow-up date
2020 Year 05 Month 08 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This study is a meta-analysis of any RCTs

Management information
Registered date
2020 Year 05 Month 09 Day
Last modified on
2020 Year 05 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046041

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.